Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GT201 Monotherapy or in Combination With PD-1 Inhibitor for Advanced Solid Tumors
NCT06144671Phase 2Recruiting
- Sponsor
- Grit Biotechnology
- Start
- Nov 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of GT201 in solid tumor, sponsored by Grit Biotechnology. Started Nov 2025; status: recruiting.
02
Drugs
GT201
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT06144671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06144671.